For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Ocular Therapeutix Inc (NASDAQ: OCUL) closed at $5.70 in the last session, down -1.72% from day before closing price of $5.80. In other words, the price has decreased by -$1.72 from its previous closing price. On the day, 4.22 million shares were traded. OCUL stock price reached its highest trading level at $6.01 during the session, while it also had its lowest trading level at $5.62.
Ratios:
We take a closer look at OCUL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 21.29 and its Current Ratio is at 21.39. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.18.
On February 09, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $15.
On April 21, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $18.Robert W. Baird initiated its Outperform rating on April 21, 2023, with a $18 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 23 ’24 when Dugel Pravin sold 21,626 shares for $5.79 per share. The transaction valued at 125,215 led to the insider holds 833,353 shares of the business.
Nayak Sanjay sold 2,274 shares of OCUL for $13,280 on May 23 ’24. The Chief Strategy Officer now owns 178,026 shares after completing the transaction at $5.84 per share. On Feb 26 ’24, another insider, SUMMER ROAD LLC, who serves as the 10% Owner of the company, bought 930,851 shares for $7.52 each. As a result, the insider paid 7,000,000 and bolstered with 8,591,401 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCUL now has a Market Capitalization of 882867200 and an Enterprise Value of 474383808. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.75 while its Price-to-Book (P/B) ratio in mrq is 2.16. Its current Enterprise Value per Revenue stands at 7.927 whereas that against EBITDA is -5.389.
Stock Price History:
Over the past 52 weeks, OCUL has reached a high of $11.31, while it has fallen to a 52-week low of $2.00. The 50-Day Moving Average of the stock is -16.41%, while the 200-Day Moving Average is calculated to be 12.25%.
Shares Statistics:
According to the various share statistics, OCUL traded on average about 2.47M shares per day over the past 3-months and 1725010 shares per day over the past 10 days. A total of 154.89M shares are outstanding, with a floating share count of 133.99M. Insiders hold about 13.49% of the company’s shares, while institutions hold 68.15% stake in the company. Shares short for OCUL as of 1715731200 were 21221363 with a Short Ratio of 8.58, compared to 1713139200 on 14646476. Therefore, it implies a Short% of Shares Outstanding of 21221363 and a Short% of Float of 13.76.
